Amwill Health Care Limited (BOM:544353)
India · Delayed Price · Currency is INR 43.14
0.00 (0.00%)
At close: Oct 16, 2026
Amwill Health Care Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 863 | 579 | 1,382 | - | - | - | |
Market Cap Growth | -17.04% | -58.10% | - | - | - | - |
Enterprise Value | 390 | 462 | 1,250 | - | - | - |
Last Close Price | 43.14 | 28.61 | 68.28 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 7.56 | 5.07 | 12.88 | - | - | - |
PS Ratio | 1.90 | 1.27 | 3.41 | - | - | - |
PB Ratio | 1.07 | 0.72 | 2.00 | - | - | - |
P/TBV Ratio | 1.07 | 0.72 | 2.00 | - | - | - |
P/FCF Ratio | 11.63 | 7.81 | 28.51 | - | - | - |
P/OCF Ratio | 10.78 | 7.24 | 24.84 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.86 | 1.02 | 3.08 | - | - | - |
EV/EBITDA Ratio | 2.99 | 3.55 | 10.75 | - | - | - |
EV/EBIT Ratio | 3.12 | 3.70 | 11.17 | - | - | - |
EV/FCF Ratio | 5.26 | 6.23 | 25.79 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.00 | 0.00 | - | - | 0.01 | 0.08 |
Debt / EBITDA Ratio | 0.01 | 0.01 | - | - | 0.01 | 0.03 |
Debt / FCF Ratio | 0.01 | 0.01 | - | - | 0.01 | 0.04 |
Net Debt / Equity Ratio | -0.59 | -0.59 | -0.04 | -0.19 | -1.48 | -1.54 |
Net Debt / EBITDA Ratio | -3.63 | -3.63 | -0.26 | -0.20 | -1.59 | -0.61 |
Net Debt / FCF Ratio | -6.37 | -6.37 | -0.63 | 0.83 | -1.52 | -0.79 |
Asset Turnover | 0.57 | 0.57 | 0.90 | 2.80 | 3.18 | 3.71 |
Inventory Turnover | 19.80 | 19.80 | 22.28 | 6.60 | 3.46 | 3.85 |
Quick Ratio | 11.83 | 11.83 | 10.18 | 10.61 | 1.08 | 0.66 |
Current Ratio | 12.39 | 12.39 | 11.11 | 11.39 | 1.51 | 1.13 |
Return on Equity (ROE) | 15.25% | 15.25% | 24.85% | 114.88% | 102.28% | 1280.13% |
Return on Assets (ROA) | 9.88% | 9.88% | 15.47% | 65.45% | 26.72% | 28.74% |
Return on Invested Capital (ROIC) | 27.90% | 18.68% | 25.22% | 210.03% | - | - |
Return on Capital Employed (ROCE) | 15.50% | 15.50% | 16.10% | 94.20% | 83.30% | 209.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 13.24% | 19.72% | 7.76% | - | - | - |
FCF Yield | 8.60% | 12.81% | 3.51% | - | - | - |
Dividend Yield | 1.16% | 1.73% | - | - | - | - |
Buyback Yield / Dilution | -23.64% | -23.64% | -3.71% | -0.02% | - | - |
Total Shareholder Return | -22.48% | -21.91% | -3.71% | -0.02% | - | - |